Vasomotor Symptoms (Hot Flashes) in Menopause When Estrogen Therapy Is Contraindicated
Hot flashes are among the most common and disruptive symptoms of menopause — yet for some patients, standard estrogen-based therapy is not an option. A separate, evidence-informed protocol addresses this specific clinical situation.
Clinical Scenario
This protocol applies to women experiencing vasomotor symptoms — particularly hot flashes — in the context of menopause, where there is a contraindication to estrogen therapy. Because estrogen-containing regimens cannot be used in this population, an alternative treatment pathway is needed.
Clinical Goal
The primary target is reduction of vasomotor symptoms, specifically hot flashes.
Treatment Approach
When estrogen is contraindicated, a progestogen-alone approach is among the options that may be considered — however, the specific agents, their selection criteria, and the full structured regimen are detailed in the complete protocol below.
References
- Progestogens alone may be used in women with contraindications to estrogen therapy.
- Use of a progestogen alone may be effective in treating VMS, but the safety of long term use has not been established.
View source ↗